- Home
- IMNM vs NCDL Comparison
IMNM vs NCDL Comparison
Compare IMNM & NCDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- NCDL
- Stock Information
- Founded
- IMNM 2006
- NCDL 2019
- Country
- IMNM United States
- NCDL United States
- Employees
- IMNM N/A
- NCDL N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- NCDL
- Sector
- IMNM Health Care
- NCDL
- Exchange
- IMNM Nasdaq
- NCDL NYSE
- Market Cap
- IMNM 945.8M
- NCDL 814.1M
- IPO Year
- IMNM 2020
- NCDL N/A
- Fundamental
- Price
- IMNM $10.60
- NCDL $16.37
- Analyst Decision
- IMNM Strong Buy
- NCDL Hold
- Analyst Count
- IMNM 5
- NCDL 4
- Target Price
- IMNM $26.40
- NCDL $16.63
- AVG Volume (30 Days)
- IMNM 965.4K
- NCDL 147.3K
- Earning Date
- IMNM 08-11-2025
- NCDL 08-06-2025
- Dividend Yield
- IMNM N/A
- NCDL 12.50%
- EPS Growth
- IMNM N/A
- NCDL N/A
- EPS
- IMNM N/A
- NCDL N/A
- Revenue
- IMNM $10,938,000.00
- NCDL N/A
- Revenue This Year
- IMNM N/A
- NCDL N/A
- Revenue Next Year
- IMNM $259.34
- NCDL N/A
- P/E Ratio
- IMNM N/A
- NCDL N/A
- Revenue Growth
- IMNM N/A
- NCDL N/A
- 52 Week Low
- IMNM $5.15
- NCDL $14.21
- 52 Week High
- IMNM $16.81
- NCDL $18.01
- Technical
- Relative Strength Index (RSI)
- IMNM 60.20
- NCDL 43.06
- Support Level
- IMNM $10.33
- NCDL $16.36
- Resistance Level
- IMNM $11.08
- NCDL $17.11
- Average True Range (ATR)
- IMNM 0.60
- NCDL 0.28
- MACD
- IMNM 0.04
- NCDL -0.09
- Stochastic Oscillator
- IMNM 72.31
- NCDL 10.99
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About NCDL NUVEEN CHURCHILL DIRECT LENDNG CORP
Nuveen Churchill Direct Lending Corp is a specialty finance company focused predominantly on investing in senior secured loans to private equity-owned U.S. middle market companies. It invest in senior secured loans that typically pay floating interest rates and are senior in the capital structure to junior debt and equity.